0001179110-19-012567.txt : 20191209
0001179110-19-012567.hdr.sgml : 20191209
20191209212423
ACCESSION NUMBER: 0001179110-19-012567
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191205
FILED AS OF DATE: 20191209
DATE AS OF CHANGE: 20191209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McCamish Mark Anthony
CENTRAL INDEX KEY: 0001390798
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37977
FILM NUMBER: 191276411
MAIL ADDRESS:
STREET 1: C/O FORTY SEVEN, INC.
STREET 2: 1490 O'BRIEN DRIVE, SUITE A
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001012477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
STREET 2: BALLYCOOLIN
CITY: DUBLIN
STATE: L2
ZIP: 15
BUSINESS PHONE: 636-449-1830
MAIL ADDRESS:
STREET 1: 16640 CHESTERFIELD GROVE ROAD
STREET 2: SUITE 200
CITY: CHESTERFIELD
STATE: MO
ZIP: 63005
FORMER COMPANY:
FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA
DATE OF NAME CHANGE: 19960422
4
1
edgar.xml
FORM 4 -
X0306
4
2019-12-05
0
0001012477
AVADEL PHARMACEUTICALS PLC
AVDL
0001390798
McCamish Mark Anthony
C/O AVADEL PHARMACEUTICALS PLC
BLOCK 10-1 BLANCHARDSTOWN CORP. PARK
DUBLIN
L2
15
IRELAND
1
0
0
0
Stock Option (right to buy)
5.92
2019-12-05
4
A
0
60000
0.00
A
2019-12-05
ADSs
60000
60000
D
The stock options shall vest and become exercisable in the following manner: 33% on December 5, 2020; 33% on December 5, 2021; and the remaining 34% on December 5, 2022.
The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
/s/ Phillandas T. Thompson as attorney in fact for Mark Anthony McCamish
2019-12-09